Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-compliance

BACKGROUND: Bridging anticoagulation is used in vitamin-K antagonist (VKA) patients undergoing invasive procedures and involves complex risk assessment in order to prevent thromboembolic and bleeding outcomes. OBJECTIVES: Our aim was to assess guideline compliance and identify factors associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Moesker, M. J., de Groot, J. F., Damen, N. L., Bijsterveld, N. R., Twisk, J. W. R., Huisman, M. V., de Bruijne, M. C., Wagner, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681479/
https://www.ncbi.nlm.nih.gov/pubmed/31391790
http://dx.doi.org/10.1186/s12959-019-0204-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681479/
https://www.ncbi.nlm.nih.gov/pubmed/31391790
http://dx.doi.org/10.1186/s12959-019-0204-x

Ejemplares similares